To form the evidence base for the Biosimilar Awareness Initiative (the Initiative), the Department procured the University of South Australia (UniSA) to conduct a comprehensive literature search and review.
The Review Authors, Michael Ward, PhD BPharm (Hons), Stephanie Reuter Lange, PhD BSc(Hons) & Kirsten Staff, PhD, MPharm, PGCertEd, conducted a search of all international and Australian clinical, academic and policy journals and other media articles reported in English language between 1 June 2004 and 28 April 2016.
The findings of the literature review are used to ensure that the core messages of the Initiative remain relevant in a changing environment.
The issues-based themes below have been used to categorise the literature within the report:
- Determining Access and Subsidisation: Regulatory, Government and Healthcare Provider Biosimilar Medicine Policies to Subsidisation, Switching and Substitution;
- Biosimilar Medicine Uptake: Current Practice of Prescribers, Pharmacists and Patients;
- Adverse Events and Health Outcomes of Biosimilar Medicines (Pharmacovigilance): Impact of Substitution, Switching and Extrapolation of Indication; and
- Evaluating and Improving Stakeholder Biosimilar Awareness, Confidence, Attitudes and Acceptance of Biosimilar Medicine.
You can access the Literature Review:
Initial – April 2016:
May 2016 - September 2016
September 2016 - December 2016
March 2017 - May 2017
June 2017 - August 2017
September 2017 – November 2017
Ongoing literature reviews will be conducted to support the evidence base required for the communication activities of the Initiative.